COVID 19 Serology in Pulmonologists

COVID 19 Serology in Pulmonologists : Pneumo Sero Cov

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04422574

Acronym

Pneumoserocov

Enrollment

Registered

2020-06-09

Start date

2020-05-01

Completion date

2020-05-30

Last updated

2020-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid 19

Keywords

Covid 19, serology

Brief summary

Respiratory physicians are highly exposed workers to Covid-19 as they perform spirometry, endoscopy, and manage Covid-19 in first line for most of them. Moreover, none reported to have apply increased levels of protection for performing these acts in the most active period of viral circulation, until the lockdown. Whether they were most frequently immunized against SARS-CoV-2 at the end of the first wave than the general population is of utmost importance individually but also worldwide

Interventions

None listed

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Pulmonologists of Languedoc Roussillon * Actively working * Registered

Exclusion criteria

* refusal to participate

Design outcomes

Primary

Measure	Time frame	Description
covid 19 serology	1 day	covid 19 serology with cross sectional
risk factors for positive serology testing	1 day	risk factors for positive serology testing with cross sectional

Countries

France

Outcome results